NCT01363999View on ClinicalTrials.gov

A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

atorvastatin

single dose of atorvastatin on day 1

DRUG

dalcetrapib

single dose of dalcetrapib on day 1

Trial Locations (1)

8011

Christchurch

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01363999 - A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers | Biotech Hunter | Biotech Hunter